Kozak & Associates’s Zogenix, Inc. ZGNX Stock Holding History

Kozak & Associates’s Portfolio ZGNX Stock Details ZGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-35	Closed	-$1K	–	395
2021 Q3	$1K	Buy	+35	New	+$547	﹤0.01%	324

Other funds holding ZGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Kozak & Associates's ZGNX Position: Q4 2021 in Review

Kozak & Associates sold out of Zogenix, Inc. (ZGNX) in Q4 2021, closing a stake of 35 shares — an estimated $1K sold.

Kozak & Associates first reported a position in ZGNX in Q3 2021 and held it in 1 quarter. The position peaked at $1K in Q3 2021. 156 funds tracked by Wall St. Rank hold ZGNX as of Q4 2021.

Kozak & Associates reported no remaining Zogenix, Inc. position as of Q4 2021 after selling out during the quarter.
Kozak & Associates sold 35 Zogenix, Inc. shares in Q4 2021, an estimated $1K.
Kozak & Associates first reported a position in Zogenix, Inc. in Q3 2021 and held it in 1 quarter.
Kozak & Associates's Zogenix, Inc. position peaked at $1K in Q3 2021.
156 funds tracked by Wall St. Rank held Zogenix, Inc. as of Q4 2021.

Based on Kozak & Associates's 13F filing for Q4 2021, filed 11 Mar 2022.